Robert E Landry
EVP Finance CFO at Regeneron Pharmaceuticals, Inc. (REGN)
Robert E Landry has filed 37 insider reports with the SEC since August 2021, as director at Cytokinetics Inc (CYTK), director at Zymeworks Inc. (ZYME) and EVP Finance CFO at Regeneron Pharmaceuticals, Inc. (REGN). In the last 12 months Robert E Landry sold $147K of stock on the open market. In the latest filing, on September 15, 2026, Robert E Landry sold 1,000 shares of Cytokinetics Inc (CYTK) for $72.1K at an average of $72.13.
- Filings
- 37
- Companies
- 3
- Bought on market
- None
- Sold on market
- $9.29M
Companies where Robert E Landry is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince February 2025 | 8,184 | $147K | $51.65 | Sep 15, 2026 | |||
| Directorsince August 2025 | $25.84 | Jan 13, 2026 | |||||
| EVP Finance CFO | 23,693 | $9.15M | $957.76 | Feb 6, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 15, 2026-$72.1KCYTKDirector Landry Robert E sold $72,130 worth of shares (1,000 units at $72.13), decreasing direct ownership by 11% to 8,184 unitsForm 4Open-market sale
- Sep 11, 2026-$74.7KCYTKDirector Landry Robert E sold $74,660 worth of shares (1,000 units at $74.66), decreasing direct ownership by 10% to 9,184 unitsForm 4Open-market sale
- May 27, 2026CYTKDirector Landry Robert E was granted 2,851 shares, increasing direct ownership by 39% to 10,184 unitsForm 4Grant or award
- Jan 12, 2026ZYMESEC Form 4 filed by Director Landry Robert EForm 4Grant or award
- Aug 11, 2025ZYMESEC Form 4 filed by Director Landry Robert EForm 4Grant or award
- Aug 10, 2025ZYMENew insider Landry Robert E claimed no ownership of stock in the companyForm 3New insider
- May 14, 2025CYTKDirector Landry Robert E was granted 7,333 sharesForm 4Grant or award
- Feb 10, 2025CYTKSEC Form 4 filed by Director Landry Robert EForm 4Grant or award
- Feb 10, 2025CYTKRobert E Landry became an insiderForm 3New insider
- Feb 2, 2024REGNLandry Robert E exercised 400 shares at a strike of $378.98 and covered exercise/tax liability with 281 shares, increasing direct ownership by 0.50% to 23,693 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 31, 2024REGNLandry Robert E exercised 400 shares at a strike of $378.98 and covered exercise/tax liability with 282 shares, increasing direct ownership by 0.50% to 23,574 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 24, 2024REGNLandry Robert E exercised 1,600 shares at a strike of $378.98 and covered exercise/tax liability with 1,128 shares, increasing direct ownership by 2% to 23,456 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 17, 2024REGNLandry Robert E exercised 500 shares at a strike of $378.98 and covered exercise/tax liability with 354 shares, increasing direct ownership by 0.64% to 22,984 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 12, 2024REGNLandry Robert E exercised 800 shares at a strike of $378.98 and covered exercise/tax liability with 568 shares, increasing direct ownership by 1% to 22,838 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 4, 2024REGNLandry Robert E exercised 500 shares at a strike of $378.98 and covered exercise/tax liability with 342 shares, increasing direct ownership by 0.70% to 22,606 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 3, 2024REGNLandry Robert E exercised 1,750 shares at a strike of $378.98 and covered exercise/tax liability with 1,109 shares, increasing direct ownership by 3% to 22,448 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Dec 28, 2023REGNLandry Robert E exercised 1,600 shares at a strike of $378.98 and covered exercise/tax liability with 1,154 shares, increasing direct ownership by 2% to 21,807 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Dec 13, 2023REGNLandry Robert E covered exercise/tax liability with 7,104 shares and exercised 1,000 shares at a strike of $378.98, decreasing direct ownership by 22% to 21,361 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Dec 11, 2023REGNLandry Robert E covered exercise/tax liability with 4,234 shares, decreasing direct ownership by 13% to 27,465 unitsForm 4Shares withheld for taxes or exercise price
- Aug 23, 2023-$188KREGNSEC Form 4: Landry Robert E sold $188,212 worth of shares (223 units at $844.00), decreasing direct ownership by 0.70% to 31,699 unitsForm 4Open-market sale
- Mar 28, 2023-$980KREGNSEC Form 4 filed by Landry Robert EForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 6, 2023-$1.16MREGNSEC Form 4: Landry Robert E sold $1,158,204 worth of shares (1,491 units at $776.80) as part of a pre-agreed trading plan, exercised 3,000 shares at a strike of $381.92 and covered exercise/tax liability with 2,248 shares, decreasing direct ownership by 2% to 32,105 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 16, 2022REGNSEC Form 4: Landry Robert E was granted 3,853 shares, increasing direct ownership by 13% to 32,844 unitsForm 4Grant or award
- Dec 9, 2022REGNSEC Form 4: Landry Robert E exercised 3,000 shares at a strike of $381.92 and covered exercise/tax liability with 2,753 shares, increasing direct ownership by 0.86% to 28,991 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative10b5-1 plan
- Dec 2, 2022-$462KREGNSEC Form 4: Landry Robert E covered exercise/tax liability with 1,890 shares, sold $461,564 worth of shares (610 units at $756.66) as part of a pre-agreed trading plan and exercised 2,500 shares at a strike of $381.92Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 1, 2022-$365KREGNSEC Form 4: Landry Robert E exercised 2,000 shares at a strike of $381.92, covered exercise/tax liability with 1,518 shares and sold $365,386 worth of shares (482 units at $758.06) as part of a pre-agreed trading planForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 17, 2022-$265KREGNSEC Form 4: Landry Robert E exercised 1,500 shares at a strike of $381.92, covered exercise/tax liability with 1,142 shares and sold $264,741 worth of shares (358 units at $739.50) as part of a pre-agreed trading planForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 11, 2022-$1.61MREGNSEC Form 4: Landry Robert E exercised 9,500 shares at a strike of $388.46, covered exercise/tax liability with 7,313 shares and sold $1,606,602 worth of shares (2,187 units at $734.61) as part of a pre-agreed trading planForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 1, 2022-$220KREGNSEC Form 4: Landry Robert E exercised 1,500 shares at a strike of $399.66, covered exercise/tax liability with 1,184 shares and sold $219,875 worth of shares (316 units at $695.81) as part of a pre-agreed trading planForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 29, 2022-$1.85MREGNSEC Form 4: Landry Robert E exercised 14,500 shares at a strike of $426.56, covered exercise/tax liability with 11,817 shares and sold $1,845,630 worth of shares (2,683 units at $687.90) as part of a pre-agreed trading planForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 21, 2022-$208KREGNSEC Form 4: Landry Robert E sold $207,900 worth of shares (300 units at $693.00) as part of a pre-agreed trading plan, exercised 400 shares at a strike of $381.92 and covered exercise/tax liability with 312 shares, decreasing direct ownership by 0.73% to 28,744 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 17, 2022-$260KREGNSEC Form 4: Landry Robert E sold $260,038 worth of shares (383 units at $678.95) as part of a pre-agreed trading plan, exercised 365 shares at a strike of $381.92 and covered exercise/tax liability with 286 shares, decreasing direct ownership by 1% to 28,956 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 13, 2021-$76.9KREGNSEC Form 4: Landry Robert E exercised 1,500 shares at a strike of $555.67, covered exercise/tax liability with 2,081 shares and sold $76,850 worth of shares (116 units at $662.50) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 29,260 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 10, 2021-$520KREGNSEC Form 4: Landry Robert E was granted 3,971 shares, exercised 4,250 shares at a strike of $399.66, covered exercise/tax liability with 3,469 shares and sold $520,477 worth of shares (781 units at $666.42) as part of a pre-agreed trading plan, increasing direct ownership by 15% to 29,957 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 17, 2021-$439KREGNSEC Form 4: Landry Robert E covered exercise/tax liability with 3,069 shares, sold $439,299 worth of shares (681 units at $645.08) as part of a pre-agreed trading plan and exercised 3,750 shares at a strike of $399.66Form 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 31, 2021REGNSEC Form 4: Landry Robert E exercised 1,000 units of Common Stock at a strike of $555.67 and covered exercise/tax liability with 917 units of Common Stock, increasing direct ownership by 0.32% to 25,986 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Aug 10, 2021-$553KREGNSEC Form 4: Landry Robert E sold $553,484 worth of Common Stock (901 units at $614.30), exercised 5,000 units of Common Stock at a strike of $381.92 and covered exercise/tax liability with 4,099 units of Common StockForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivativeOpen-market sale10b5-1 plan
Compare Robert E Landry with
- Robert E Landry vs Paul Andrew Moore1 shared
- Robert E Landry vs B Lynne Parshall1 shared
- Robert E Landry vs Jason Pitofsky1 shared
- Robert E Landry vs Andrew J Murphy1 shared
- Robert E Landry vs Huda Y Zoghbi1 shared
- Robert E Landry vs George L Sing1 shared
Other insiders at the same companies
- Scott PlatshonZYME
- Paul Andrew MooreZYME
- B Lynne ParshallCYTK
- Jason PitofskyREGN
- Andrew J MurphyREGN
- Huda Y ZoghbiREGN
- George L SingREGN
- Christine A PoonREGN
- Christopher R. FenimoreREGN
- Joseph J LarosaREGN
- Fady Ibraham MalikCYTK
- Kathryn GuariniREGN
- Michael S BrownREGN
- Marion McCourtREGN
- Robert I BlumCYTK
- Andrew CallosCYTK
Questions about Robert E Landry
- What is Robert E Landry's role at Regeneron Pharmaceuticals, Inc.?
- Robert E Landry reports to the SEC as EVP Finance CFO at Regeneron Pharmaceuticals, Inc. (REGN), according to the latest filing on February 6, 2024. Robert E Landry has also filed as director at Cytokinetics Inc (CYTK) and director at Zymeworks Inc. (ZYME).
- How many shares does Robert E Landry own?
- After the latest filing that states it, Robert E Landry directly owned 8,184 shares of Cytokinetics Inc (CYTK) and 23,693 shares of Regeneron Pharmaceuticals, Inc. (REGN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert E Landry bought or sold stock recently?
- The most recent open-market sale was on September 15, 2026: sold 1,000 shares of Cytokinetics Inc (CYTK) for $72.1K at an average of $72.13.
- How do I get alerts when Robert E Landry files?
- Follow Robert E Landry on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert E Landry filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Robert E Landry (SEC CIK 0001585160). Totals count each trade once, skipping amendments whose original is on file, from Aug 10, 2021 on. View on SEC EDGAR